IRIM11 lends money to developers, shopping malls, hospitals, and solar plants via CRIs (Brazilian real-estate receivables certificates — debt securities backed by real estate) and passes on the interest every month tax-free. There are 157 different CRIs in the portfolio — very few Brazilian REIT-style funds (FIIs) feature such risk dispersion. Iridium Gestão de Recursos manages the fund with a Good rating and a zero performance fee since 2025, leaving more earnings in the unitholder's pocket. In Nov/2025, the fund grew more than 18-fold by absorbing IRDM11; the unit price dropped in the following months as IRDM unitholders sold upon receiving units without an affinity for the thesis — it was a base adjustment, not a quality issue, and the unit price has stabilized since. Monthly income fluctuates with inflation: recurring level of R$ 0.75–0.80/unit (market dividend yield ~14.9% p.a., tax-exempt). The last DPU paid was R$ 0.77 (Aug/26), within the recurring range — the peak of R$ 1.18 occurred in Jul/26, inflated by reserves and one-off events. As the IPCA, Brazil's official inflation index, has receded in recent months, income is expected to soften slightly ahead, but the fund holds R$ 0.31/unit in reserves to cushion weaker months.
Investment thesis
IRIM11 is a newly formed multi-strategy paper FII case study resulting from a merger: the fund emerges from the absorption of IRDM11 (Nov/25) with net assets of R$ 2.90B, a granular portfolio (157 CRIs + FIIs), and a competitive fee structure (0.98% total, no performance fee). The ~21% discount to book value and the dividend yield of ~14.9% (market) attract investors seeking high-grade paper with granularity. Without structural leverage (a one-off reverse repo of 2.4% of net assets, at CDI+0.4%, covers April allocations and will be settled with CRI principal repayments), with a marked-to-market IPCA+10.6% rate and a 3.44-year duration, the fund is a legitimate vehicle for exposure to corporate real estate credit. Risks: reliance on high IPCA inflation to sustain DPU (the indicator has receded in recent months and is already pressing forward distributions), ongoing recycling of legacy IRDM FIIs (variable quality), and potential selling pressure from legacy IRDM11 unitholders in the coming months.
Who it's for
Monthly income investors who accept DPU volatility tied to IPCA inflation
Moderate to aggressive profile with tolerance for quarterly fluctuations
Those seeking extreme granularity (157 CRIs in 1 ticker)
Investors who value competitive fees (0.98% total) and the absence of a performance fee
Those betting on a book value discount in a post-reorganization FII
Who it's not for
Conservative investors who cannot tolerate DPU volatility tied to monthly IPCA inflation
Investors requiring absolute cash flow predictability (DPU fluctuated from R$ 0.69 to R$ 0.89 over the last 4 months)
Those seeking a brick-and-mortar FII — IRIM11 is predominantly paper
Profiles that do not accept the recycling risk of the post-merger portfolio
Points of attention and risks
Reciclagem da carteira de FIIs herdada do IRDM11 ainda em curso
The FII allocation (~20% of net assets) includes legacy assets of questionable quality (HCTR11, DEVA11, MANA11, TORD11) that are being gradually divested. In Jul/26, the fund divested ~0.10% of net assets in FIIs, notably closing out its position in HDOF11; previous trades had already been executed (CPSH11, EIRA11) along with secondary sales of RBHY11 and TORD11. The process generates negative FII earnings in some months during the transition.
Reliance on IPCA to sustain DPU — an indicator already receding
78% of net assets are in IPCA-indexed CRIs (88% of the CRI portfolio). Management itself points out in the Jul/26 Management Report that the lower IPCA of recent months 'is expected to impact upcoming distributions'. To cushion this, an additional reserve of R$ 0.03/unit was constituted, closing July with an accumulated reserve of R$ 0.31/unit — a cushion that softens, but does not eliminate, DPU volatility (which has already ranged from R$ 0.69 in Jan/26 to R$ 1.18 in Jun/26).
One-off leverage (reverse repo) — non-structural
In Jul/26, the fund resorted to a reverse repo operation of 2.4% of net assets (at CDI+0.4%) to fund new allocations (~6% of net assets) originating from April prepayments. Management states that this leverage is NOT structural and will be settled with normal CRI principal repayments in the coming months. Monitor settlement.
Bewiki CRI — payment delay and risk monitoring
The Bewiki CRI (hospitals) experienced a payment delay in May/26 — the amount entered cash in Jun/26. Management confirms that hospital operations are active and revenues are growing, but the asset requires monitoring. Given the size of the portfolio (157 granular CRIs), the individual impact is diluted.
Concentration in real estate sector borrowers (residential and allotments)
A relevant portion of the CRIs finances residential projects by developers (MRV, Cury, Gafisa, EKKo) and land subdivisions (FGR, Inlote, Alphaville). A negative cycle for the residential market could increase delinquency across multiple assets simultaneously, even though the portfolio is granular in number of contracts.
Return to the IFIX as a potential technical catalyst
IRIM11 exited IFIX, Brazil's listed real-estate fund index, following the Nov/2025 merger. Returning to the index (when net assets and liquidity consolidate) could generate buying flow from indexed funds and ETFs — a positive catalyst for the unit price.
Acquisition of physical real estate via SPE — Brookfield solar plants
In Jun/26, IRIM11 signed the acquisition of two solar plants (UFV MG Bom Sucesso and UFV RJ Corcovado) for R$ 62.1M (~2.1% of net assets). This adds exposure to physical real estate/SPEs beyond the CRI/FII portfolio, diversifying the income source but also the operational risk profile.
Is IRIM11 trustworthy?
Our current reading of IRIM11 is BUY, with a score of 7.7/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
Second in the bucket with a robust book of IPCA-linked CRIs (78% of net assets) and a tax-exempt dividend yield of 13.9%. The recycling of the portfolio inherited from IRDM11 and reliance on a receding IPCA weigh on results, but Iridium maintains scale and diversification above the average.
Is IRIM11 safe?
Safety in a REIT is not yes or no — it is how much risk you accept. IRIM11 has a moderado risk profile. What that means in practice:
Component
Level
Concentração
1.5
Price volatility
3.0
Dividend volatility
3.0
Liquidez
2.5
Underlying asset risk
2.5
Financial risk / leverage
1.0
Risks that don't show up in IRIM11's fact sheet
Selling pressure from legacy IRDM11 unitholders
IRDM11 had 258,920 unitholders who received IRIM11 units without necessarily sharing an affinity for the thesis. The quote fell 17% in the 4 months post-merger; selling pressure may persist until the unitholder base stabilizes.
Typically, uninterested unitholders exit within 6 to 12 months. An average daily trading volume of R$ 2.7M/day absorbs the flow gradually.
Inherited FII portfolio of variable quality
19% of net assets are in 23 FIIs—some inherited from IRDM (DEVA11, HCTR11, MANA11, TORD11, VSLH11) with troubled histories. FII earnings had a negative impact of R$ 2.3M in Oct/25.
Iridium is executing gradual portfolio recycling (Mar/26: -0.11% of net assets via sales; swaps via CPSH11 and EIRA11). The process is public and disclosed.
Indirect concentration in distributed generation (Utilities)
The utilities sector accounts to 18.9% of the CRI portfolio—significant exposure to Origo Energia, FazSol, Aurora, AXS, Faro Energy, Thopen, and GS Souto. Regulatory tariff risks or sector credit issues could have an impact.
Pulverization across multiple borrowers (≥8) and predominantly senior tranches; each CRI involves multiple special purpose entities (SPEs).
CRIs under monitoring (≈1% of net assets)
Echer (0.58% of net assets, dation in payment agreement signed, implementation phase as of May/26), EKKO III (0.23%, under judicial enforcement with a recent favorable ruling), TMI Villa Jardim (0.82%, MTM rate of 14.5%). These are isolated cases, but they represent credit stress.
Small aggregate exposure (<1.5%). Iridium has a track record of recovering distressed CRIs.
Scenarios for IRIM11
Scenario
Description
Sustained monthly IPCA above 0.40%
Strong inflation drives up the monetary correction of CRIs and expands DPU to R$ 0.85+/unit. The current COPOM baseline scenario suggests controlled inflation at 4.5%.
Declining Selic rates + reopening of capital flows to FIIs
Selic is projected at 11% over 12 months (Focus survey). Falling rates generate mark-to-market gains in IPCA+ CRIs via a 3.46-year duration.
Completion of the FII portfolio recycling
Iridium completes the divestment of legacy IRDM FIIs (HCTR, DEVA, etc.) and reallocates capital into CRIs with attractive cap rates, boosting recurring DPU.
Persistently low IPCA (<0.15% monthly)
Contained inflation compresses DPU to the R$ 0.65–0.70/unit range, bringing the dividend yield down to ~12.5%.
Coordinated exit of legacy IRDM unitholders
Prolonged selling pressure may extend the P/BV discount—unit prices could test R$ 60 before stabilizing.
Defaults in concentrated CRIs
Defaults in 1 to 2 concentrated CRIs (>2% of net assets)—such as XPIN Tucano, Mooca, Hospital Bahia, Evolua, or Pantanal—could impair 5% to 10% of the DPU.
Conclusion
IRIM11, 6 months after the incorporation of IRDM11 (11/18/2025), has consolidated as a multi-strategy credit FII with R$ 2.97B in net assets, featuring 157 highly diversified CRIs (~72% of assets), 23 FIIs (19%), and an MTM yield of IPCA+10.3% with a 3.46-year duration. The transaction combined Iridium's expertise in CRIs (IRDM) with IRIM's lighter fee structure (no performance fee, 0.98% total).
The April/26 DPU (announced on 05/12/26) jumped to R$ 0.90/unit — the highest since the merger and above the estimated range (R$ 0.70-0.85) — driven by March/26 IPCA inflation (0.32%) and principal repayments received. The Structured Monthly Report for April also showed that net cash tripled to R$ 315M (10.6% of net assets) held in BTG Selic fixed-income funds, giving the manager 'dry powder' to reallocate into new CRIs at attractive cap rates.
On the other hand, the fund still faces transition challenges: the unitholder base (208,981 in Apr/26) includes legacy investors from IRDM11 with varying affinity for the thesis — selling pressure dropped the unit price by 17% over the 4 months post-merger (R$ 74.96 → R$ 62.45) before stabilizing at R$ 64-66. The recycling of the legacy FII portfolio (DEVA, HCTR, MANA, TORD) is still underway, with Iridium executing gradual swaps and sales.
The opportunity lies in the discount to book value — a P/BV of 0.78 (22% below the R$ 84.38 book value) is attractive for a fund with extreme diversification, zero leverage, and low fees. Combined with a projected decline in the Selic rate (Focus: 11% in 12 months) and the recent robust DPU, the base scenario points to a total return of ~25% in 12 months (DY of 14-16% + repricing of ~11%).
Frequently asked questions
Is IRIM11 good? Is it worth investing?
Current recommendation: BUY. Rating 7.7/10. IRIM11 lends money to developers, shopping malls, hospitals, and solar plants via CRIs (Brazilian real-estate receivables certificates — debt securities backed by real estate) and passes on the interest every month tax-free. There are 157 different CRIs in the portfolio — very…
IRIM11: buy or sell?
Our current read on IRIM11 is “BUY”. Rating 7.7/10. Assess it against your risk profile and the points of attention listed above.
What are IRIM11's risks?
The main points of attention for Iridium FII include: Reciclagem da carteira de FIIs herdada do IRDM11 ainda em curso; Reliance on IPCA to sustain DPU — an indicator already receding; One-off leverage (reverse repo) — non-structural; Bewiki CRI — payment delay and risk monitoring.
Who is IRIM11 suitable for?
IRIM11 is suitable for: Monthly income investors who accept DPU volatility tied to IPCA inflation Moderate to aggressive profile with tolerance for quarterly fluctuations Those seeking extreme granularity (157 CRIs in 1 ticker)